Asthma +me (CE-marked, Class 1 Medical Device): RCT for digital alternative care pathway to unblock paediatric asthma outpatient clinics.

哮喘是英国儿童和年轻人中最常见的慢性疾病，也是NHS的优先事项(NHS，英格兰)。英国有93.2万名儿童接受哮喘治疗。这是紧急入院的最常见原因，英国死于儿童哮喘的风险在经合组织国家中排名第三(英国哮喘)。目前的护理管理计划基于初级保健就诊和根据需要转介到专科诊所。《哮喘英国》最近的报告《漏网之鱼》指出，有必要为患有困难或严重哮喘的儿童和青少年转介到儿科专科中心，因为他们没有专家护理的风险最大。我们的CE标志哮喘+Me护理解决方案适用于患有稳定但困难或严重哮喘的儿童和年轻人，将用于支持他们及其家人在家中保持良好状态。结合了：*自我护理技术*教育*培训*支持*与初级、二级和三级护理的数据共享，为了支持现有的门诊护理，哮喘+我是一种解决方案，它可以帮助英国国家医疗服务体系儿科中心满足良好的自我护理指南，并满足哮喘英国在其《漏网之鱼》报告(7月2018).https://www.asthma.org.uk/globalassets/get-involved/external-affairs-campaigns/publications/severe-asthma-report/auk-severe-asthma-gh-final.pdf)中确定的需求

Asthma is the most common chronic medical condition among children and young people in the UK and an NHS priority (NHS England). 932,000 children in England receive treatment for asthma. It is the most frequent reason for emergency admission and the UK has the third highest risk of death from childhood asthma in OECD nations (Asthma UK).The current care management programme is based on primary care visits and referral to specialist clinics as required. Asthma UK's recent report ""Slipping through the net"" identifies the need for referral to specialist paediatric centres for children and young people with difficult or severe asthma as they are at greatest risk without expert care.Our CE-Marked Asthma+me care solution for children and young people with stable but difficult or severe asthma and will be used to support them and their families keep well at home.It combines:* self-care technology* education* training* support* data sharing with primary, secondary and tertiary care, to support existing out-patient careAsthma+me is a solution that helps NHS paediatric centres meet NICE guidelines for self-care and addresses the needs identified by Asthma UK in their ""Slipping through the net"" report (July 2018).https://www.asthma.org.uk/globalassets/get-involved/external-affairs-campaigns/publications/severe-asthma-report/auk-severe-asthma-gh-final.pdf